RecruitingHeart Failure
Alleviant ALLAY-HFrEF Study
Eligible age
18+ yrs
Accepts
All genders
Locations
19 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.
Sponsor: Alleviant Medical, Inc.
You may qualify if…
- ✓ LVEF ≤ 40%
- ✓ NYHA class II, III or ambulatory IV HF
- ✓ Receiving optimal, maximally tolerated, stable GDMT
You may not qualify if…
- ✕ Advanced heart failure
- ✕ Life-expectancy \< 12 months
- ✕ Evidence of right heart dysfunction
Where it's recruiting
California
Los Angeles · Sacramento · San Diego · San Francisco
Florida
Delray Beach · Pensacola · Tampa
Georgia
Decatur
Illinois
Naperville
Louisiana
Houma · New Orleans
Massachusetts
Boston
Minnesota
Minneapolis
Missouri
St Louis
Nevada
Las Vegas
New Jersey
Browns Mills · Englewood
New York
New York · Rochester
North Carolina
Asheville · Durham · Raleigh
Source: ClinicalTrials.gov · NCT06812533 · last updated 2026-10-06